Invention Grant
US07648976B2 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
失效
17-烯丙基氨基-17-去甲氧基格尔德霉素多晶型物和制剂
- Patent Title: 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
- Patent Title (中): 17-烯丙基氨基-17-去甲氧基格尔德霉素多晶型物和制剂
-
Application No.: US11595005Application Date: 2006-11-08
-
Publication No.: US07648976B2Publication Date: 2010-01-19
- Inventor: Peter J. Licari , Timothy Leaf , Ruchir P. Desai , Jorge L. Galazzo , Greg O. Buchanan , Stephen William Watt , Alexander Redvers Eberlin , Robert Arslanian
- Applicant: Peter J. Licari , Timothy Leaf , Ruchir P. Desai , Jorge L. Galazzo , Greg O. Buchanan , Stephen William Watt , Alexander Redvers Eberlin , Robert Arslanian
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Elliott Korsen Fox Rothschild LLP
- Main IPC: C07D225/04
- IPC: C07D225/04 ; C07D225/06 ; A61K9/00
Abstract:
Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
Public/Granted literature
- US20070203110A1 17-Allylamino-17-demethoxygeldanamycin polymorphs and formulations Public/Granted day:2007-08-30
Information query
